Sign up to save your podcasts
Or
Share FOURIER Presenter, Dr Marc Sabatine, Interviewed
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FOURIER Presenter, Dr Marc Sabatine, Interviewed
Dr Mandrola gets the details on the PCSK9 inhibitor evolocumab, and asks the $64,000 (or is that $14,000) question about cost-effectiveness.
View all episodes
By MedscapeDr Mandrola gets the details on the PCSK9 inhibitor evolocumab, and asks the $64,000 (or is that $14,000) question about cost-effectiveness.